Opens in a new tab

MSC - Page 5

Exploring the Potential of Umbilical Cord as a Source for Mesenchymal Stem Cell-Based Therapy

Because of its ability to simultaneously activate multiple mechanisms, including paracrine, trophic, immunomodulatory, and differentiation, researchers consider mesenchymal stem cells to be an effective option for regenerative medicine.  After years of active research, bone marrow-derived MSCs (BM-MSCs) have been a prevalent source for MSC-based studies. There is also active research using MSCs from a variety…

Mesenchymal Regenerative Medicine: A Review of Clinical Trials for Multiple Sclerosis

stem cell therapy for multiple sclerosis (MS) is a progressive disease of the central nervous system (CNS) that occurs as a result of the body’s immune system attacking the protective sheath, or myelin, responsible for covering nerve fibers. Characterized by progressive nerve deterioration and damage of the nerve fibers, MS is currently estimated to affect…

Exploring the Use of Human Umbilical Cord Mesenchymal Stem Cell-derived Extracellular Vesicles to Improve Airway Inflammation in Cases of COPD

Chronic obstructive pulmonary disease (COPD) is an incurable and debilitating disease characterized by chronic and progressive inflammation that leads to small airway obstruction and emphysema.   According to the World Health Organization, COPD is the third leading cause of death and is responsible for an estimated 3.2 million deaths each year. Between 80 and 90% of…

What Are Adult Stem Cells?

Stem cells are essential in understanding human development, disease, injury, and potential treatments and cures. However, since the initial research on these critical cells began with embryonic stem cells, many people dismiss the benefits of stem cell research and treatment as controversial. Unfortunately, that dismissal ignores what may be of adult stem cells, which are more…

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson’s Disease

Research has shown neuroinflammation to have a significant role in the pathogenesis of Parkinson’s disease (PD). Much of this same research has also demonstrated mesenchymal stem cells (MSCs), and specifically, allogeneic bone marrow-derived MSCs, can be effectively used as an immunomodulatory therapy for the potential treatment of PD. The goal of Schiess et al.’s study…

Bone Marrow-Derived MSCs to Reduce Neural Damage and Prevent Multiple System Atrophy

Multiple system atrophy (MSA) is a rare, degenerative adult-onset neurological disorder that affects your body's involuntary functions, including blood pressure, breathing, bladder function, and motor control. MSA also demonstrates several symptoms similar to those accompanying stem cell therapy for Parkinson disease’s disease, including slow movement, stiff muscles, and loss of balance[1]. Considering the rapid and…

Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Preclinical to Clinical Studies

Multiple sclerosis (MS) is a chronic inflammatory disease that attacks myelin, the protective sheath that covers nerves and causes progressive and serious communication issues between the brain, central nervous system, and the rest of the body[1]. Currently, it's estimated that over 2.3 million people worldwide, and over one million people in the US have a…

Physical Therapy for Pain Management

Up to 50 million Americans suffer from chronic or long-term pain. Missing work, the inability to do recreational activities, lack of concentration, and poor mental health are all side effects of living with chronic pain. However, one of the last things pain sufferers want to do may be the most effective treatment for chronic pain: exercise,…

Efficacy of DMSA and EDTA in Chelation of Toxic Metals and Improvement of the Number of Stem Cells in Circulation

Metal toxicity, resulting from lead, mercury, aluminum, and arsenic, continues to be a significant public health concern and contributes to a number of serious health issues, including damage to the central and peripheral nervous systems, compromised kidney and liver function, and damage to the cardiovascular system.  Specifically, toxic metals appear to contribute to oxidative stress…

The Efficacy Of Wharton’s Jelly Mesenchymal Stem Cells For Treating Type 2 Diabetes

According to recent data from the CDC, an estimated 30 million Americans currently have type 2 diabetes mellitus (T2DM), and another 88 million are considered to be prediabetic[1].  Occurring most often as a result of being overweight and/or sedimentary and often resulting in severe kidney, heart, or vision issues, T2DM has demonstrated to be difficult…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.